CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM
CNLM was delisted on the 8th of June, 2016.
9 hedge funds and large institutions have $14.8M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
29% more funds holding
Funds holding: 7 → 9 (+2)
12% more capital invested
Capital invested by funds: $13.3M → $14.8M (+$1.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$1.54M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.02K |
| 4 |
Morgan Stanley
New York
|
+$99 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAMP
1
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $5.47M | – | – | – |
|
|
WAM
2
Weiss Asset Management
Boston,
Massachusetts
| $4.21M | +$1.54M | +155,000 | +58% |
|
|
AA
3
AQR Arbitrage
Greenwich,
Connecticut
| $3.48M | – | – | – |
|
|
KIM
4
Karpus Investment Management
Pittsford,
New York
| $1.31M | – | – | – |
|
|
GCL
5
Glazer Capital LLC
New York
| $224K | – | – | – |
|
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $124K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $12K | +$12.2K | +1,233 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2K | +$1.02K | +103 | +103% |
|
|
9
Morgan Stanley
New York
| – | +$99 | +10 | New |
|
CNLM Hedge Fund Activity: Q4 2015 in Review
9 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q4 2015, worth a combined $14.8M — up 12% from $13.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CNLM positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Weiss Asset Management, adding an estimated $1.54M.
- 9 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q4 2015, up from 7 in Q3 2015.
- Funds reported $14.8M of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q4 2015, up 12% quarter-over-quarter.
- 2 funds opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q4 2015 and 0 closed out, a net change of +2 holders.
- The largest CB PHARMA ACQUISISTION CORP SHS (CYM) buyer in Q4 2015 was Weiss Asset Management, an estimated $1.54M added.
Based on aggregated 13F filings for Q4 2015.